Corporate information
Registration country
Company type
Developer of immunotherapies for cancer and other diseases.Funding rounds
Series B USD 8,000,000
USD 8,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
GV. | The venture capital arm of Alphabet Inc. (Formerly Google Ventures.) | 4,000,000 (USD 4,000,000) Initial investment. | |
|
Quark Venture Inc | 4,000,000 (USD 4,000,000) Initial investment. |
Series B USD 16,000,000
USD 16,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
NanoDimension Inc (ND Capital) | Led the round. | ||
|
Polaris Partners | Led the round. |
Investment activity status
Active investor